IBM’s $68 Billion Selloff Triggers Legal Probes and a High-Stakes Earnings Test
Published on 07/21/2026 at 17:04 | Redaktion boerse-global.de
The tremors from IBM’s mid-July profit warning are still shaking the stock, and the reverberations now extend well beyond the trading floor. Multiple US law firms have opened investigations into whether the company misled investors about its sales pipeline before the July 14 pre-announcement that erased roughly $68 billion from its market capitalization. Hagens Berman Sobol Shapiro and Bleichmar Fonti & Auld are both probing potential securities law violations, zeroing in on how management communicated the trajectory of big-ticket deals in the weeks leading up to the shock.
That legal scrutiny adds an extra layer of pressure to Wednesday’s earnings report, when IBM is set to deliver its full second-quarter results after the closing bell. The preliminary numbers are already on the table: revenue of $17.2 billion, up a meager 1% year-over-year and well below the $17.86 billion consensus, while adjusted earnings per share of $2.93 missed estimates by about 9 cents. The stock plunged more than 25% in a single session, the steepest one-day drop in decades.
Now the question is whether chief executive Arvind Krishna can convince the market that the miss was a timing glitch—not a structural breakdown. “We stumbled,” Krishna admitted, attributing the shortfall to a sudden shift in customer budgets away from software and mainframes toward AI servers and memory chips. Clients, he said, rushed to lock in scarce infrastructure components before expected price hikes, distorting typical buying patterns. The infrastructure segment bore the brunt, with sales sliding 7%, a stark reversal from the 51% surge the z16 mainframe program had delivered in the year-ago period.
The bull case rests on the theory that delayed deals will eventually close. Supporting that view, Red Hat’s revenue growth accelerated to 11% in constant currency, the distributed infrastructure backlog swelled to roughly $500 million, and the new z17 mainframe cycle is running at nearly 130% of its predecessor’s pace. IBM is also sticking to its strategic spending plan, announcing more than $10 billion in quantum computing investments over five years, and reaffirming its second-quarter revenue forecast and year-to-date free cash flow of $4.8 billion. Some analysts remain upbeat: Wedbush’s Dan Ives raised his price target to $350 a share, seeing the selloff as a buying opportunity.
Should investors sell immediately? Or is it worth buying IBM?
Yet the bear camp has plenty of ammunition. Krishna himself conceded that large customer deals simply did not close as planned, and that cybersecurity concerns further gummed up purchasing decisions. The software segment grew only 5%, far below the double-digit rates that Bank of America argues investors now demand. Consulting revenue stagnated, and HSBC cut its rating to Reduce with a $191 target, the lowest on the Street. Stifel’s David Grossman slashed his target to $235 from $290 but held his Buy rating, citing limited visibility into demand through January 2027. The average analyst price target has fallen to $273.40 from $298.30, according to a survey of 27 analysts—still implying roughly 29% upside from current levels.
Meanwhile, Stifel’s sum-of-the-parts analysis assigns IBM an enterprise value of $257 billion, well above the current market cap of around $205 billion, with Red Hat alone valued at $62.9 billion. But Grossman cautioned that a breakup might not unlock immediate value. Other observers point to IBM’s disjointed AI portfolio—Red Hat, watsonx, governance tools—as a reason execution has lagged unified competitors.
Technically, the shares look washed out. The 14-day relative strength index sits at 31.3, deep in oversold territory, and the stock changes hands at €185.18, just 3.73% above its 52-week low of €178.52. It trades 21% below its 200-day moving average. The options market is pricing in a 50% probability that the stock will move more than 6.59% in either direction after Wednesday’s print.
IBM at a turning point? This analysis reveals what investors need to know now.
What investors need to hear is not merely a beat on the quarter’s confirmed numbers, but credible evidence that the “delayed deals” are turning into signed contracts and that the budget shift was a one-off. If software growth stays in the mid-single digits accompanying a lowered full-year outlook, new lows below €178.52 are plausible. If Krishna can demonstrate that the pipeline is converting, the oversold conditions could spark a sharp relief rally. The legal docket will take longer to resolve, but Wednesday’s earnings call is the first, critical chance for IBM to reclaim the narrative.
Ad
IBM Stock: New Analysis - 21 July
Fresh IBM information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
